1. Home
  2. FEED vs XAIR Comparison

FEED vs XAIR Comparison

Compare FEED & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$0.92

Market Cap

5.6M

Sector

N/A

ML Signal

N/A

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.46

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEED
XAIR
Founded
2003
2011
Country
United States
United States
Employees
14
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FEED
XAIR
Price
$0.92
$0.46
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
414.6K
251.7K
Earning Date
04-15-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.09
EPS
N/A
N/A
Revenue
N/A
$3,705,000.00
Revenue This Year
N/A
$122.00
Revenue Next Year
N/A
$58.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
219.67
52 Week Low
$0.84
$0.15
52 Week High
$6.09
$3.78

Technical Indicators

Market Signals
Indicator
FEED
XAIR
Relative Strength Index (RSI) 32.67 41.08
Support Level $0.84 $0.41
Resistance Level $1.54 $0.59
Average True Range (ATR) 0.11 0.05
MACD 0.00 0.00
Stochastic Oscillator 12.76 33.70

Price Performance

Historical Comparison
FEED
XAIR

About FEED ENvue Medical Inc. Common Stock

ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: